Literature DB >> 6744285

Measurement and characterization of membrane-bound and soluble epoxide hydrolase activities in resting mononuclear leukocytes from human blood.

J Seidegård, J W DePierre, R W Pero.   

Abstract

Membrane-bound and soluble epoxide hydrolase activities in the mononuclear cell fraction from human blood have been characterized using cis- and trans-stilbene oxides as substrates, respectively. Because of the low activities in these cells, it was necessary to modify assay procedures developed for rat and mouse liver in the following ways: (a) the substrates were relatively highly labeled (2 Ci/mmol) and carefully purified; (b) the incubation time was extended to 45 to 60 min, during which period the activities were linear; (c) as many as 6 million cells were used for a single assay, which was also within the linear range of the procedure. The membrane-bound epoxide hydrolase characterized in this manner has an apparent Vmax of 7.26 pmol product formed per min per 10(7) cells and an apparent Km of 9.96 microM. The pH optimum was observed to be around 9.8. The dependence of this activity on temperature showed its optimum at 40 degrees. The soluble epoxide hydrolase activity has an apparent Vmax of about 8.26 pmol product formed per min per 10(7) cells, an apparent Km of 1.63 microM, a pH optimum of 6.2 to 6.8, and a temperature optimum at 60 degrees. Using these techniques, these activities have also been determined in other blood components, i.e., lymphocytes, monocytes, granulocytes, erythrocytes, platelets, and plasma. Lymphocytes account for most of the epoxide hydrolase activity towards cis-stilbene oxide, and all of the activity towards trans-stilbene oxide is in the human mononuclear cell fractions. Different substances known to affect rodent epoxide hydrolases were tested for their effects on the human mononuclear blood cell activities. Interestingly, 1,1,1-trichloropropane 2,3-epoxide, a potent inhibitor of liver microsomal epoxide hydrolase in different species including rat, mouse, and human, had little or no effect on the membrane-bound activity measured here. However, cyclohexene oxide inhibits this membrane-bound activity 60%. The soluble epoxide hydrolase is inhibited to 90% of control levels by chalcone epoxide. The membrane-bound and soluble epoxide hydrolase activities determined in 27 subjects varied from 8.2 to 18.5 and from 3.5 to 17.0 pmol product formed per min per 10(7) cells, respectively. The mean coefficient of intraindividual variation, determined with three subjects measured four times each over the course of 18 days, was approximately 10% for both enzyme activities.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6744285

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  17 in total

1.  Monoclonal antibodies reveal multiple forms of expression of human microsomal epoxide hydrolase.

Authors:  Hongying Duan; Akira Takagi; Hidekazu Kayano; Isamu Koyama; Christophe Morisseau; Bruce D Hammock; Toshitaka Akatsuka
Journal:  Toxicol Appl Pharmacol       Date:  2012-01-28       Impact factor: 4.219

2.  Soluble epoxide hydrolase expression in a porcine model of arteriovenous graft stenosis and anti-inflammatory effects of a soluble epoxide hydrolase inhibitor.

Authors:  William G Sanders; Christophe Morisseau; Bruce D Hammock; Alfred K Cheung; Christi M Terry
Journal:  Am J Physiol Cell Physiol       Date:  2012-05-23       Impact factor: 4.249

3.  Biological effects in a chemical factory with mutagenic exposure. II. Analysis of unscheduled DNA synthesis and adenosine diphosphate ribosyl transferase, epoxide hydrolase, and glutathione transferase in resting mononuclear leukocytes.

Authors:  R Pero; L Hagmar; J Seidegård; T Bellander; R Attewell; S Skerfving
Journal:  Int Arch Occup Environ Health       Date:  1988       Impact factor: 3.015

4.  Proceedings of the British Pharmacological Society. Clinical Pharmacology Section. 14-16 April 1993. Abstracts.

Authors: 
Journal:  Br J Clin Pharmacol       Date:  1993-08       Impact factor: 4.335

5.  Metabolism of ciamexon by human liver microsomes: an investigation into the formation of stable, chemically reactive and cytotoxic metabolites.

Authors:  M D Tingle; B K Park
Journal:  Br J Clin Pharmacol       Date:  1990-05       Impact factor: 4.335

6.  Cytosolic epoxide hydrolase in humans: development and tissue distribution.

Authors:  G M Pacifici; A Temellini; L Giuliani; A Rane; H Thomas; F Oesch
Journal:  Arch Toxicol       Date:  1988       Impact factor: 5.153

7.  Apparently normal phenytoin metabolism in a patient with phenytoin-induced rash and lymphadenopathy.

Authors:  J H Maguire; G Wettrell; A Rane
Journal:  Br J Clin Pharmacol       Date:  1987-10       Impact factor: 4.335

8.  Genotoxic risk for humans due to work place exposure to ethylene oxide: remarkable individual differences in susceptibility.

Authors:  J Fuchs; U Wullenweber; J G Hengstler; H G Bienfait; G Hiltl; F Oesch
Journal:  Arch Toxicol       Date:  1994       Impact factor: 5.153

9.  Inhibition of the soluble epoxide hydrolase by tyrosine nitration.

Authors:  Eduardo Barbosa-Sicard; Timo Frömel; Benjamin Keserü; Ralf P Brandes; Christophe Morisseau; Bruce D Hammock; Thomas Braun; Marcus Krüger; Ingrid Fleming
Journal:  J Biol Chem       Date:  2009-08-24       Impact factor: 5.157

10.  Hydrolysis of cis- and trans-epoxyeicosatrienoic acids by rat red blood cells.

Authors:  Houli Jiang; Angela G Zhu; Magdalena Mamczur; Christophe Morisseau; Bruce D Hammock; John R Falck; John C McGiff
Journal:  J Pharmacol Exp Ther       Date:  2008-04-29       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.